Dr. Assouline-Dayan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Park Way
Haverhill, MA 01830
Education & Training
- Technion-Israel Inst of Technology Faculty of MedicineClass of 1999, MD, Cum Laude
Certifications & Licensure
- NH State Medical License 2022 - 2026
- MA State Medical License 2019 - 2024
- OH State Medical License 2017 - 2023
- IA State Medical License 2013 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- Israeli Board of MedicinGastroenterology and Hepatology
Clinical Trials
- The Effects of Cannabinoid on Patients With Non-GERD Related Non Cardiac Chest Pain Start of enrollment: 2011 Feb 01
- Bethanechol for Eosinophilic Esophagitis Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 265 citationsEfficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic EsophagitisIkuo Hirano, Evan S. Dellon, Jennifer D. Hamilton, Margaret H. Collins, Kathryn A. Peterson
Gastroenterology. 2019-10-05 - 42 citationsLong-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic EsophagitisEvan S. Dellon, Margaret H. Collins, Marc E. Rothenberg, Yehudith Assouline-Dayan, Larry Evans
Clinical Gastroenterology and Hepatology. 2021-03-01 - 155 citationsRPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.Ikuo Hirano, Margaret H. Collins, Yehudith Assouline-Dayan, Larry Evans, Sandeep K. Gupta
Gastroenterology. 2019-02-01
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: